ASX is updating Guidance Note 1 Applying for Admission – ASX Listings to provide greater transparency to potential early-stage technology, biotechnology and medical technology listing applicants about the factors that ASX takes into account when assessing their suitability for admission.

These factors are already part of ASX’s admissions processes. ASX has spoken about them at briefings and conferences over the last 18 months and is now bringing them into the Guidance Note. 

ASX is making some other amendments to the Guidance Note to reflect ASX’s existing admission practices and policy, along with general tidy-ups. These will be of interest to all listing applicants and their professional advisers.

A mark-up comparing the updated Guidance Note to the current version is available here.

The updated Guidance Note will take effect from 30 May 2025. The Guidance Note will be able to be accessed via ASX Online and on the ASX Listing Rules page on the ASX website.

What do I need to do by when?

The updated Guidance Note will take effect from 30 May 2025.

Need more information?

Issued by

Listings Compliance

Contact information

Addison Ma
Manager, Listings Compliance

+61 2 9227 0871
Addison.Ma@asx.com.au

Disclaimer